News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Henry N. Young, PhD

Articles by Henry N. Young, PhD

AJMC

Innovation, Affordability, Access: Alzheimer Disease Drugs and the Inflation Reduction Act

ByNiying Li, PhD, MSc,Smita Rawal, PhD,Henry N. Young, PhD,Lorenzo Villa Zapata, PhD

June 13th 2024

The authors explore the economic impact and accessibility challenges of new Alzheimer disease drugs under the Inflation Reduction Act, with emphasis on Medicare, pricing, and health care equity.

Physicians' Perceptions of Relevant Prescription Drug Costs: Do Costs to the Individual Patient or to the Population Matter Most?

ByWilliam H. Shrank, MD, MSHS,George J. Joseph, MS,Niteesh K. Choudhry, MD, PhD,Henry N. Young, PhD,Susan L. Ettner, PhD,Peter Glassman, MBBS, MSc,Steven M. Asch, MD, MPH,Richard L. Kravitz, MD, MSPH

September 1st 2006

Do the Incentives in 3-Tier Pharmaceutical Benefit Plans Operate as Intended? Results From a Physician Leadership Survey

ByWilliam H. Shrank, MD, MSHS,Henry N. Young, PhD,Susan L. Ettner, PhD,Peter Glassman, MBBS, MSc,Steven M. Asch, MD, MPH,Richard L. Kravitz

January 15th 2005

Latest Updated Articles

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access